• Tea A J van Voorden, Dennis den Hartog, Soesman Nicolaj M R NMR Department of Surgery, Francisus Gasthuis & Vlietland, Rotterdam, the Netherlands., Jakma Tijs S C TSC Department of Surgery, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Marco Waleboer, Maarten Staarink, Bruijninckx Milko M M MMM Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands., Frank Nijman, Simon P Knops, Lieshout Esther M M Van EMMV Trauma Research Unit, Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., and Schep Niels W L NWL Department of Surgery, Maasstad Hospital, Rotterdam, the Netherlands..
• Trauma Research Unit, Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: t.vanvoorden@erasmusmc.nl.
• Injury. 2020 Apr 1; 51 (4): 1038-1044.

BackgroundIn 2040 the estimated number of people with a hip fracture in the Netherlands will be about 24,000. The medical care for this group of patients is complicated and challenging. Multidisciplinary approaches aim to improve clinical outcome. Quality indicators that gain insight in the treatment and outcome of hip fracture patients may help to optimize and monitor the standard of medical care. The Dutch Hip Fracture Audit (DHFA) is a new multidisciplinary quality indicator that is implemented in the Dutch hospitals in 2017.AimThe aim of this study was to determine the effect of the implementation of the DHFA on 30-day mortality, length of hospital stay and time until surgery in elderly with a hip fracture in the Netherlands.MethodsA multicenter retrospective comparative cohort study was conducted and data were extracted from the Dutch Nationwide Trauma Registration (LTR). Included were patients aged 60 years and older with a hip fracture (femoral neck and trochanteric) and admitted in one of the ten participating hospitals registered in 2015 and 2017. Data from 2015, before implementation of DHFA, were compared with data from 2017, when the DHFA was implemented. The primary outcome was 30-day mortality; secondary outcomes were length of hospital stay and time until surgery. Multivariable regression models were used to compare outcomes between groups.Results3808 patients were included, 1839 in the 2015 cohort and 1969 in the 2017 cohort. 29% was male; mean age 82 years. The multilevel analysis showed a positive non-significant difference between groups on the primary outcome30-day mortality (OR adjusted 1.23, 95%CI 0.93 - 1.63). The secondary outcomes length of hospital stay (adjusted effect estimates -0.002, 95%CI -0.03 - 0.03) and time until surgery (adjusted effect estimates 0.292, 95%CI -2.68 - 3.26) showed no differences between groups.ConclusionsImplementation of the DHFA quality indicator does have a positive non-significant trend on 30-day mortality, but showed no impact on length of hospital stay and time until surgery. More research on relevant quality indicators seems therefore mandatory.Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

22 keywords...

hide…